Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells

Diabetes

Volumn 54, Issue 3, 2005, Pages 818-829

  Ramana, Kota V ^a   Friedrich, Brian ^a   Tammali, Ravinder ^a   West, Matthew B ^b   Bhatnagar, Aruni ^b   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 LYSOPHOSPHOLIPID 1 O OCTADECYL 2 O METHY RAC GLYCEROPHOSPHOCHOLINE; ALDEHYDE REDUCTASE; CHOLINE DERIVATIVE; CP 166572; DIACYLGLYCEROL; EDELFOSINE; ENZYME INHIBITOR; GLUCOSE; IDITOL DEHYDROGENASE; ISOENZYME; MANNITOL; PHOSPHOLIPASE C BETA2; PHOSPHOLIPASE C GAMMA; POLYOL; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SORBINIL; TOLRESTAT; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CATALYSIS; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; HYPERGLYCEMIA; LIPID HYDROLYSIS; MEMBRANE TRANSPORT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ALDEHYDE REDUCTASE; ANIMALS; CELLS, CULTURED; DIGLYCERIDES; ENZYME ACTIVATION; GENE EXPRESSION; HYPERGLYCEMIA; L-IDITOL 2-DEHYDROGENASE; MUSCLE, SMOOTH, VASCULAR; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN KINASE C; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 14644387496     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.3.818     Document Type: Article

References (67)

1. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581, 2002
2. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:8-13, 1979
3. Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Part I. Circulation 108:1527-1532, 2003
4. Luscher TF, Creager MA, Beckman JA, Cosentino F: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Part II. Circulation 108:1655-1661, 2003
5. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM: Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96:2551-2556, 1997
6. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB III: Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91:979-989, 1995
7. Van Belle E, Ketelers R, Bauters C, Perie M, Abolmaali K, Richard F, Lablanche JM, McFadden EP, Bertrand ME: Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 103:1218-1224, 2001
8. Brownlee M: Biochemistry and molecular cell biology of diabetes complications. Nature 414:813-820, 2001
9. Baynes JW, Thorpe SR: Role of oxidative stress in diabetes complications: a new perspective on an old paradigm. Diabetes 48:1-9, 1999
10. Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, Yan SF, Schmidt AM: RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 24:1342-1349, 2004
11. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031, 1998
12. Graier WF, Grubenthal I, Dittrich P, Wascher TC, Kostner GM: Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol 294:221-229, 1995
13. Nakamura J, Kasuya Y, Hamada Y, Nakashima E, Naruse K, Yasuda Y, Kato K, Hotta N: Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia 44:480-487, 2001
14. Natarajan R, Gonzales N, Xu L, Nadler JL: Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 187:552-560, 1992
15. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J: Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol 15:2207-2212, 1995
16. Sheetz MJ, King GL: Molecular understanding of hyperglycemia's adverse effects for diabetes complications. JAMA 288:2579-2588, 2002
17. Bhatnagar A, Srivastava SK: Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol 48:91-121, 1992
18. Yabe-Nishimura C: Aldose reductase in glucose toxicity: a potential target for the prevention of diabetes complications. Pharmacol Rev 50:21-33, 1998
19. Costantino L, Rastelli G, Vianello P, Cignarella G, Barlocco D: Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches. Med Res Rev 19:3-23, 1999
20. Dunlop M: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Internat 77:S3-S12, 2000
21. Vinik AI: Diabetic neuropathy: pathogenesis and therapy (Review). Am J Med 107:178-268, 1999
22. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK: Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 277:32063-32070, 2002
23. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK: Activation of nuclear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53:2910-2920, 2004
24. Ruef J, Liu SQ, Bode C, Tocchi M, Srivastava S, Runge MS, Bhatnagar A: Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler Thromb Vasc Biol 20:1745-1752, 2000
25. Ramana KV, Dixit BL, Srivastava S, Balendiran GK, Srivastava SK, Bhatnagar A: Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry 39:12172-12180, 2000
26. Shaw S, Wang X, Redd H, Alexander GD, Isales CM, Marrero MB: High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem 278:30634-30641, 2003
27. Shinmura K, Bolli R, Liu SQ, Tang XL, Kodani E, Xuan YT, Srivastava S, Bhatnagar A: Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 91:240-246, 2002
28. Mellor H, Parker PJ: The extended protein kinase C superfamily. Biochem J 332:281-292, 1998
29. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992
30. Lee MW, Severson DL: Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 267:C659-C678, 1994
31. Carpenter G, Ji Q: Phospholipase C-γ as a signal-transducing element. Exp Cell Res 253:15-24, 1999
32. Rhee SG: Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70:281-312, 2001
33. Wang XT, McCullough KD, Wang XJ, Carpenter G, Holbrook NJ: Oxidative stress-induced phospholipase C-γ1 activation enhances cell survival. J Biol Chem 276:28364-28371, 2001
34. Kondo T, Konishi F, Inui H, Inagami T: Differing signal transductions elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells. J Biol Chem 268:4458-4464, 1993
35. Rao GN, Delafontaine P, Runge MS: Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-γ1 in rat aortic smooth muscle cells. J Biol Chem 270:27871-27875, 1995
36. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M: TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776, 1992
37. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R: IkappaBalpha degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-α-induced κB-dependent transcription: requirement for an additional activation pathway. J Biol Chem 273:6607-6610, 1998
38. Daniel LW, Etkin LA, Morrison BT, Parker J, Morris-Natschke S, Surles JR, Piantadosi C: Ether lipids inhibit the effects of phorbol diester tumor promoters. Lipids 22:851-855, 1987
39. Whitman SP, Civoli F, Daniel LW: Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2α down-regulation. J Biol Chem 272:23481-23484, 1997
40. Igarashi M, Wakasaki H, Takahara N, Ishu H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103:185-195, 1999
41. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, Dube GP: Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 38:578-589, 2001
42. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL: Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49:1239-1248, 2000
43. Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M, Aiello LP, King GL: Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci U S A 99:721-726, 2002
44. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M: Translocation of glomerular p47phox and p67phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy. Diabetes 52:2603-2614, 2003
45. Kumar A, Hawkins KS, Hannan MA, Ganz MB: Activation of PKC-beta(I) in glomerular mesangial cells is associated with specific NF-κB subunit translocation. Am J Physiol Renal Physiol 281:F613-F619, 2001
46. Yamamoto M, Acevedo-Duncan M, Chalfant CE, Patel NA, Watson JE, Cooper DR: The roles of protein kinase C βI and βII in vascular smooth muscle cell proliferation. Exp Cell Res 240:349-358, 1998
47. Kahn SM, O'Driscoll KR, Jiang W, Borner C, Xu DB, Blackwood MA, Zhang YJ, Nomoto K, Weinstein IB: Suppression of mitogenic activity by stable expression of the regulatory domain of PKC β. Carcinogenesis 15:2919-2925, 1994
48. Hua H, Munk S, Goldberg H, Fantus IG, Whiteside CI: High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J Biol Chem 278:33951-33962, 2003
49. Leitges M, Mayr M, Braun U, Mayr U, Li C, Pfister G, Ghaffari-Tabrizi N, Baier G, Hu Y, Xu Q: Exacerbated vein graft arteriosclerosis in protein kinase Cδ-null mice. J Clin Invest 108:1505-1512, 2001
50. Fukumoto H, Naito Z, Asano G, Aramaki T: Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus. J Atheroscler Thromb 5:29-35, 1998
51. Bolli R: The late phase of preconditioning. Circ Res 87:972-983, 2000
52. Nayeem MA, Mustafa SJ: Protein kinase C isoforms and A1 adenosine receptors in porcine coronary smooth muscle cells. Vascul Pharmacol 39:47-54, 2002
53. Skaletz-Rorowski A, Waltenberger J, Muller JG, Pawlus E, Pinkernell K, Breithardt G: Protein kinase C mediates basic fibroblast growth factor-induced proliferation through mitogen-activated protein kinase in coronary smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1608-1614, 1999
54. 2. Proc Natl Acad Sci U S A 94:11233-11237, 1997
55. Xia P, Inoguchi T, Kern TS, Engerman RL, Gates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
56. Kiss Z, Tomono M: Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidyleth-anolamine hydrolysis. Biochim Biophys Acta 1259:105-108, 1995
57. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
58. Lee MW, Severson DL: Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 267:C659-C678, 1994
59. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ: Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52:2835-2840, 1992
60. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
61. Lassegue B, Alexander RW, Clark M, Akers M, Griendling KK: Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth-muscle cells. Biochem J 292:509-517, 1993
62. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
63. Bai XC, Deng F, Liu AL, Zou ZP, Wang Y, Ke ZY, Ji QS, Luo SQ: Phospholipase C-γ1 is required for cell survival in oxidative stress by protein kinase C. Biochem J 363:395-401, 2002
64. Ye K, Aghdasi B, Luo HR, Moriarity JL, Wu FY, Hong JJ, Hurt KJ, Bae SS, Sun PG, Snyder SH: Phospholipase C γ1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature 415:541-544, 2002
65. Srivastava S, Chandra A, Wang LF, Seifert WE Jr, DaGue BB, Ansari NH, Srivastava SK, Bhatnagar A: Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem 273:10893-10900, 1998
66. Srivastava S, Watowich SJ, Petrash JM, Srivastava SK, Bhatnagar A: Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38:42-54, 1999
67. Palicz A, Foubert TR, Jesaitis AJ, Marodi L, McPhail LC: Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components. J Biol Chem 276:3090-3097, 2001